As cultivated meat and other cell-based technologies move toward larger production systems, the culture medium becomes more than a laboratory ingredient. It can determine how efficiently cells grow, how consistently a process performs, and whether cells can make the transition from small-scale culture to bioreactors. A new patent application from The Cultivated B focuses on one particularly stubborn challenge: developing serum-free conditions that support cells in suspension while keeping them healthy and minimizing unwanted clumping.
Making Serum-Free Media Work at Scale
The filing (EP4745225A1) describes a defined nutrient composition built around a basal medium combined with antioxidants, selenium, insulin, transferrin, growth factors and albumin. Plant- or fungus-derived extracts, proteins or hydrolysates, including yeast extract, can also be incorporated.
The individual ingredients are familiar in cell culture. The interesting part is how the filing brings them together around a scale-up problem. Many vertebrate cells naturally grow attached to a surface. When moved into suspension, they can stick to one another and form aggregates. Large clumps can make nutrient and oxygen delivery less uniform and complicate bioreactor cultivation.
The application describes formulations intended to maintain high proliferation and long-term viability while reducing this aggregation. It also covers formulations that can work with both suspension and adherent cultures, giving the medium greater flexibility across cultivation formats.
This is an important distinction from simply replacing fetal bovine serum with a defined recipe. Serum-free media such as Essential 8 have already demonstrated that complex serum can be replaced with selected components. The Cultivated B filing instead places particular emphasis on the combination of serum-free formulation, suspension growth and reduced aggregation, while also exploring plant- and fungus-derived nutritional inputs. The application itself acknowledges earlier serum-free formulations, making its focus on scalable suspension culture especially significant.
From Cell Culture to Industrial Production
The Cultivated B develops technologies for cellular agriculture, cell lines, culture media and bioprocessing. Its broader work includes adapting cells to suspension growth and supporting the transition from laboratory-scale cultivation toward bioreactors. This filing fits directly into that strategy by addressing one of the ingredients that has to work reliably throughout that journey.
The People Behind the Filing
Congratulations and a warm thank you to the inventors: Tim Decker, Olga Pacjuk, Matheus Kolodzieij, Katharina Gräser, and Jitin Bali, for their work on advancing serum-free cell cultivation toward more flexible and scalable production systems.
I am Nidhi Mote, a biomedical scientist and science communicator with a PhD where I spent years building tiny 3D models of blood vessels (because apparently regular-sized biology wasn't complicated enough). My background sits at the crossroads of bioengineering and cell biology and these days I channel that into writing about the futures being quietly built in labs, from cellular agriculture to next-gen biotech. I care about making science legible, exciting, and maybe even a little beautiful which is why I am equally likely to reach for a pen as I am a pipette. When I am not writing, I am doodling diagrams that probably explain things better than my words do. Based in Hamburg, always happy to talk about tissue engineering, cellular agriculture, and connect with like-minded folks.
Lab Grown Technologies highlights meaningful innovations shaping the future of cellular agriculture and tissue engineering.
Join the conversation and share your thoughts on LinkedIn: linkedin.com/company/lab-grown-technologies/
This article is based on publicly available information. Lab Grown Technologies is not affiliated with the inventors or organizations mentioned.
Work with Lab Grown Technologies
We help teams present their technology and make it visible to a highly engaged audience in food and biotech, capturing interest from people and organizations that may benefit from your solution.